Related Experiment Video
Updated: Sep 4, 2025

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Challenges in the Multidisciplinary Management of Pediatric Patients with Intestinal Failure During the COVID-19
Insights
The COVID-19 pandemic disrupted pediatric intestinal failure care, impacting central venous catheter management, clinic visits, and surgical timelines, leading to significant challenges for affected children and families.
Area of Science:
- Pediatric Gastroenterology
- Infectious Disease Epidemiology
- Healthcare Management
Background:
- The COVID-19 pandemic significantly altered healthcare delivery globally.
- Pediatric patients with intestinal failure require complex, multidisciplinary care.
- Pre-existing vulnerabilities in this patient population may have been exacerbated by pandemic-related disruptions.
Purpose of the Study:
- To analyze the multifaceted impacts of the COVID-19 pandemic on the care of pediatric patients with intestinal failure.
- To identify specific challenges faced in managing central venous catheters, clinic visits, and surgical interventions.
- To assess the broader consequences on patient outcomes and emotional well-being.
Main Methods:
- Review of clinical management protocols and supply chain data during the pandemic.
- Analysis of patient care timelines, including clinic visit frequency and surgical scheduling.
- Qualitative assessment of emotional and psychosocial impacts on patients and families.
Main Results:
- Disruptions in personal protective equipment and supplies affected central venous catheter home care.
- Reduced in-person visits led to care delays and hindered progress toward enteral autonomy.
- Emotional distress among chronically ill children and families was significant.
- Delayed surgical interventions potentially postponed parenteral nutrition weaning.
Conclusions:
- The COVID-19 pandemic presented substantial challenges to the multidisciplinary care of pediatric intestinal failure.
- The full long-term effects of these disruptions on patient outcomes remain to be determined.
- Adaptations in care delivery are necessary to mitigate future pandemic-related impacts.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic had profound effects on the management of pediatric patients with intestinal failure. Limitations in personal protective equipment and other necessary supplies led to changes in home care of central venous catheters. Limitations for in-person clinic visits led to changes in care delivery systems and contributed to delays in care and delays in the progression toward enteral autonomy. The emotional strain of living with chronic illness during a pandemic caused hardships that are still being felt. Delays in surgical care also potentially delayed children weaning from parenteral nutrition. The global pandemic of COVID-19 and its far-reaching effects on society contributed to challenges and changes in the multidisciplinary care of pediatric patients with intestinal failure, of which the full effect is still unknown. [Pediatr Ann. 2022;51(7):e277-e280.].
More Related Videos
07:16An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Cystic Fibrosis: Management
Sinus disease and chronic...
Irritable Bowel Syndrome III: Medical and Nursing Management
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: